{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:08:51Z","timestamp":1781651331679,"version":"3.54.5"},"reference-count":45,"publisher":"Hindawi Limited","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3247,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2006.01147.x","type":"journal-article","created":{"date-parts":[[2006,10,12]],"date-time":"2006-10-12T03:48:10Z","timestamp":1160624890000},"page":"1401-1407","source":"Crossref","is-referenced-by-count":18,"title":["Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?"],"prefix":"10.1155","volume":"60","author":[{"given":"N. D.","family":"YEOMANS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L-E","family":"SVEDBERG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"NAESDAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2006,10,11]]},"reference":[{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2036.2000.00700.x","article-title":"Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices","volume":"14","author":"Cullen","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1016\/S0002-9343(00)00627-6","article-title":"Nonsteroidal anti-inflammatory drug prescribing: past, present and future","volume":"110","author":"Jones","year":"2001","journal-title":"Am J Med"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/1999\/361651","article-title":"The epidemiology of nonsteroidal anti-inflammatory drugs","volume":"13","author":"Tenenbaum","year":"1999","journal-title":"Can J Gastroenterol"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB4|cit4","first-page":"1001","article-title":"Factors affecting over-the-counter use of aspirin in the secondary prophylaxis of cardiovascular disease","volume":"51","author":"Bedson","year":"2001","journal-title":"Br J Gen Pract"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/j.1572-0241.2002.05974.x","article-title":"Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms","volume":"97","author":"Thomas","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"3 Suppl. 1","key":"10.1111\/j.1742-1241.2006.01147.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1053\/sarh.2002.37217","article-title":"The gastrointestinal effects of non-selective and COX-2-selective inhibitors","volume":"32","author":"Laine","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s004230000193","article-title":"Incidence and pathophysiology of peptic ulcer bleeding","volume":"386","author":"Arlt","year":"2001","journal-title":"Langenbeck's Arch Surg"},{"issue":"Suppl. 3A","key":"10.1111\/j.1742-1241.2006.01147.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/S0002-9343(00)00728-2","article-title":"Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors","volume":"110","author":"Buttgereit","year":"2001","journal-title":"Am J Med"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0149-2918(99)80020-4","article-title":"An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs","volume":"21","author":"Cheatum","year":"1999","journal-title":"Clin Ther"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/gast.2002.36013","article-title":"Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis","volume":"123","author":"Laine","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/gut.50.4.460","article-title":"Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects","volume":"50","author":"Higham","year":"2002","journal-title":"Gut"},{"issue":"Suppl. 2","key":"10.1111\/j.1742-1241.2006.01147.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S1590-8658(01)80158-4","article-title":"Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects","volume":"33","author":"Lazzaroni","year":"2001","journal-title":"Dig Liver Dis"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1572-0241.2000.02194.x","article-title":"Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor","volume":"95","author":"Goldstein","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2174\/1381612023394999","article-title":"Gastrointestinal safety of selective COX-2 inhibitors","volume":"18","author":"Hawkey","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/jama.282.20.1929","article-title":"Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs","volume":"282","author":"Langman","year":"1999","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB17|cit17","unstructured":"U.S. Food and Drug Administration Center for Drug Evaluation and Research Public Health Advisory Non-Steroidal Anti-Inflammatory Drug Products 2004. http:\/\/www.fda.gov\/cder\/drug\/advisory\/nsaids.htm"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2036.1998.00288.x","article-title":"Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users","volume":"12","author":"Cullen","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group","volume":"338","author":"Yeomans","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs","volume":"338","author":"Hawkey","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1590-8658(00)80821-X","article-title":"Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study","volume":"32","author":"Bianchi Porro","year":"2000","journal-title":"Dig Liver Dis"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1572-0241.2006.00499.x","article-title":"Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors","volume":"101","author":"Scheiman","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archinte.162.19.2248-a","article-title":"Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs","volume":"162","author":"Weaver","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-123-4-199508150-00001","article-title":"Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs. A randomized, double blind placebo controlled trial","volume":"123","author":"Silverstein","year":"1995","journal-title":"Ann Intern Med"},{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2006.01147.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.1995.tb00777.x","article-title":"The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease","volume":"9","author":"Hunt","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1111\/j.1572-0241.2005.00243.x","article-title":"Healing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trial","volume":"100","author":"Goldstein","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/j.1572-0241.2002.05774.x","article-title":"Effect of H.\u00a0pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine","volume":"97","author":"Campbell","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archinte.160.10.1455","article-title":"Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group","volume":"160","author":"Agrawal","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/rheumatology\/32.6.474","article-title":"Ranitidine in the treatment of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drugs","volume":"32","author":"Tildesley","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/gut.32.3.252","article-title":"Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers","volume":"32","author":"Lancaster-Smith","year":"1991","journal-title":"Gut"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/gut.28.2.226","article-title":"Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease","volume":"28","author":"Manniche","year":"1987","journal-title":"Gut"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1053\/gast.1997.v112.pm9178671","article-title":"Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration","volume":"112","author":"Hudson","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/00365529409091417","article-title":"Nizatidine in therapy and prevention of non-steroidal anti-inflammatory drug-induced gastroduodenal ulcer in rheumatic patients","volume":"206","author":"Simon","year":"1994","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2006.01147.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2036.1988.tb00768.x","article-title":"Treatment of NSAID-induced gastrointestinal lesions with cimetidine: an international multicentre collaborative study","volume":"2","author":"Bijlsma","year":"1988","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0016-5085(19)34189-7","article-title":"Role of gastric acid in aspirin-induced irritation in the rat","volume":"53","author":"Brodie","year":"1967","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1440-1681.1996.tb02754.x","article-title":"Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH","volume":"23","author":"Elliott","year":"1996","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2006.01147.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"A510","DOI":"10.1016\/S0016-5085(03)82584-2","article-title":"Integrated gastric acidity can predict the prevention of naproxen-induced gastroduodenal pathology in normal subjects","volume":"124","author":"Plachetka","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB38|cit38","first-page":"649","article-title":"Progress with proton pump inhibition","volume":"65","author":"Bell","year":"1992","journal-title":"Yale J Biol Med"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00365528909091243","article-title":"Relationship between inhibition of acid secretion and healing of peptic ulcers","volume":"166","author":"Chiverton","year":"1989","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0889-8553(05)70147-3","article-title":"The non-steroidal anti-inflammatory drugs controversy","volume":"29","author":"Yeomans","year":"2000","journal-title":"Gastroenterol Clin North Am"},{"issue":"4","key":"10.1111\/j.1742-1241.2006.01147.x-BIB41|cit41","article-title":"Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients","author":"Ford","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1053\/gast.1996.v110.pm8608881","article-title":"Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer","volume":"110","author":"Labenz","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/gut.34.6.748","article-title":"Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs","volume":"34","author":"Hudson","year":"1993","journal-title":"Gut"},{"issue":"Suppl. 2A","key":"10.1111\/j.1742-1241.2006.01147.x-BIB44|cit44","first-page":"41","article-title":"Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage: actions of therapeutic agents","volume":"84","author":"Ivey","year":"1998","journal-title":"Am J Med"},{"key":"10.1111\/j.1742-1241.2006.01147.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.00102.2004","article-title":"Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin","volume":"288","author":"Allen","year":"2005","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2006.01147.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2006.01147.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T09:53:42Z","timestamp":1707299622000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2006.01147.x"}},"subtitle":["RANITIDINE THERAPY FOR HEALING PEPTIC ULCERS"],"short-title":[],"issued":{"date-parts":[[2006,10,11]]},"references-count":45,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01147.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10,11]]}}}